1h Free Analyst Time
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Insulin Pens Market Report Speak directly to the analyst to clarify any post sales queries you may have.
There will be an increase in demand for Insulin Pens in the forecast period due to its long-term cost-effectiveness and other advantages such as accuracy, better convenience, and ease of use over conventional insulin pens. Other than high-income countries with full diabetes insurance coverage, several middle-income countries have started adopting it with advanced technologies. In some countries in Europe, for example, France, Spain, and Germany, doctors highly prescribe insulin pens under the health insurance coverage with a reasonable cutting cost, which makes it more cost-effective than insulin syringes.
The insulin pens market is expected to grow at a CAGR of 6.26% during the forecast period
GLOBAL INSULIN PENS MARKET SEGMENTATION
- The traditional insulin pens dominated the market. However, smart insulin pens are expected to increase significantly in the forecast period across the globe.
- Hospitals & Clinics dominated the distribution channel segment because of the easy access to insulin pens in the hospital pharmacies and thus doctors are increasingly prescribing insulin pens in both high- and low-income countries.
Segmentation by Product
- Traditional
- Smart
Segmentation by Usage
- Disposable
- Reusable
Segmentation by Distribution Channel
- Hospitals & Clinics
- Standalone Pharmacies
- Online
GEOGRAPHICAL OUTLOOK
- Europe dominated the market due to high prevalence of diabetes in the region. APAC region is expected to grow at faster rate in the forecast period with the CAGR of 7.26% because of the increase in awareness and the target population.
Segmentation by Geography
- Europe
- Germany
- UK
- France
- Spain
- Italy
- North America
- US
- Canada
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE
VENDOR LANDSCAPE
The leading vendors in the insulin pen industry are Lilly, Medtronic, Novo Nordisk, and Sanofi. The market competition is solely based on quality, quantity, technology, safety, and price.
KEY VENDORS
- Lilly
- Medtronic
- Novo Nordisk
- Sanofi
OTHER PROMINENT VENDORS
- BD
- Biocon
- Diamesco
- Emperra
- Guangzhou Medsinglong Medical Equipment
- HK Zion Industry
- Jiangsu Delfu Medical Device
- Owen Mumford
- Shanghai Umitai Medical Technology
- Sun Medical Products
- Suzhou Peng Ye Medical Technology Co., Ltd.
- Triones Technology (Guangzhou)
- Ypsomed
THE REPORT INCLUDES:
1. The analysis of the global Insulin Pens market provides market size and growth rate for the forecast period 2022-2027.
2. It offers comprehensive insights into current industry trends, trend forecast, and growth drivers about the global Insulin Pens market.
3. The report provides the latest analysis of market share, growth drivers, challenges, and investment opportunities.
4. It offers a complete overview of market segments and the regional outlook of the global Insulin Pens market.
5. The report offers a detailed overview of the vendor landscape, competitive analysis, and critical market strategies to gain competitive advantage.
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market at a Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Growth Restraints
11 Market Landscape
12 Product
13 Usage
14 Distribution Channel
15 Geography
16 Europe
17 North America
18 Apac
19 Latin America
20 Middle East & Africa
21 Competitive Landscape
22 Key Company Profiles
23 Other Prominent Vendors
24 Report Summary
25 Quantitative Summary
26 Appendix
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 260 |
Published | March 2022 |
Forecast Period | 2022 - 2027 |
Estimated Market Value ( USD | $ 1088.44 Million |
Forecasted Market Value ( USD | $ 1567.1 Million |
Compound Annual Growth Rate | 6.2% |
Regions Covered | Global |
No. of Companies Mentioned | 17 |